chr1-234392503-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_005646.4(TARBP1):c.4610G>A(p.Gly1537Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,613,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005646.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152130Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000756 AC: 19AN: 251416 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000581 AC: 85AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 43AN XY: 727168 show subpopulations
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4610G>A (p.G1537D) alteration is located in exon 29 (coding exon 29) of the TARBP1 gene. This alteration results from a G to A substitution at nucleotide position 4610, causing the glycine (G) at amino acid position 1537 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at